No Detail Found!

Efficacy of Streptokinase in Diabetic Patients with Acute St Elevation Myocardial Infarction.

Author(s)
Muhammad Adeel Alam Department of Pharmacology, Ayub Medical College, Abbottabad,
Yasir Hayat Department of Cardiology, North West Hospital, Peshawar,
Shakeel Ahmad Jadoon Department of Medicine, Ayub Medical College, Abbottabad, Pakistan
Bibi Munazza Physiology, Ayub Medical College, Abbottabad, Pakistan
Aamir Nazir Physiology, Ayub Medical College, Abbottabad, Pakistan
Wajid Ali Department of Pharmacology, Ayub Medical College, Abbottabad,
Abstract
Background: The efficacy of streptokinase in Myocardial Infarction is usually evaluated either by coronary angiographic measurement of thrombolysis in myocardial infarction or by the measurement of ST segment resolution at 90 minutes after streptokinase infusion, in 12-lead electrocardiogram (ECG). This study was carried out to determine the efficacy of streptokinase in diabetic patients with acute ST Elevation Myocardial Infarction (STEMI). Methods: This was a descriptive cross-sectional study carried out at the Cardiology Department of Ayub Teaching Hospital from June 2015 to July 2016. A total of 169 patients with STEMI were included in the study using non-probability consecutive sampling. Patients were administered injection Streptokinase in a dose of 1.5 million units, diluted in 100 ml of normal saline, in 1 hour and repeat ECG was done at 90 mins to assess ST segment resolution. A repeat ECG was performed within 90 minutes of start of therapy to check the efficacy of fibrinolytic therapy. Fifty percent or >50% reduction in height of ST segment elevation (ST resolution) towards baseline within 90 minutes after start of streptokinase infusion was considered effective. Results: Mean age of the patients was 53.76±4.76 years. Most of the patients were >55 years of age. Out of 169 patients, 69.23% (n=117) were male while 30.77% (n=52) were female. Streptokinase administration in acute STEMI in diabetics revealed ST segment resolution at 90 mins in 15.38% (n=26), while 84.62% (n=143) showed no ST segment resolution. Conclusion: Thrombolytic therapy is not effective in diabetic subjects with STEMI. In diabetics to improve outcome, newer strategies such as peri-infarction metabolic control and primary angioplasty should be investigated.
Publication Details
Page(s) 10-12
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 15, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Streptokinase, ST segment elevation myocardial infarction, STEMI
0

Citations

0

Downloads

50

Views